These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration. Furino C; Ferrara A; Cardascia N; Besozzi G; Alessio G; Sborgia L; Boscia F J Cataract Refract Surg; 2009 Sep; 35(9):1518-22. PubMed ID: 19683147 [TBL] [Abstract][Full Text] [Related]
12. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Algvere PV; Steén B; Seregard S; Kvanta A Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062 [TBL] [Abstract][Full Text] [Related]
13. Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study. Demirel S; Bilici S; Batıoğlu F; Özmert E Ophthalmic Res; 2016; 56(1):35-40. PubMed ID: 27027523 [TBL] [Abstract][Full Text] [Related]
14. Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment. El-Mollayess GM; Noureddine BN; Bashshur ZF Semin Ophthalmol; 2011 May; 26(3):69-76. PubMed ID: 21609219 [TBL] [Abstract][Full Text] [Related]
15. Correlation between aqueous flare and chorioretinal neovascularization in age-related macular degeneration following intravitreal bevacizumab injections. Errera MH; Girmens JF; Ayello-Scheer S; Nourry H; Warnet JM; Sahel JA; Barale PO J Fr Ophtalmol; 2014 Jan; 37(1):30-5. PubMed ID: 24209785 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Bashshur ZF; Bazarbachi A; Schakal A; Haddad ZA; El Haibi CP; Noureddin BN Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245 [TBL] [Abstract][Full Text] [Related]